{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:35:27Z","timestamp":1782311727021,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T00:00:00Z","timestamp":1500076800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s40618-017-0729-4","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T14:54:35Z","timestamp":1500130475000},"page":"223-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring"],"prefix":"10.1007","volume":"41","author":[{"given":"A.","family":"Mantovani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rigolon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Civettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bolzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Morani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bonapace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Zoppini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bonora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,15]]},"reference":[{"key":"729_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","volume":"131","author":"BF Culleton","year":"1999","unstructured":"Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131:7\u201313","journal-title":"Ann Intern Med"},{"key":"729_CR2","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Kang D-H, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359:1811\u20131821","journal-title":"N Engl J Med"},{"key":"729_CR3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/BF03346733","volume":"34","author":"G Zoppini","year":"2011","unstructured":"Zoppini G, Targher G, Bonora E (2011) The role of serum uric acid in cardiovascular disease in type 2 diabetic and non-diabetic subjects. A narrative review. J Endocrinol Invest 34:881\u2013886","journal-title":"J Endocrinol Invest"},{"key":"729_CR4","first-page":"640","volume":"19","author":"A Giorgi De","year":"2015","unstructured":"De Giorgi A, Fabbian F, Pala M, Tiseo R, Parisi C, Misurati E, Manfredini R (2015) Uric acid: friend or foe? Uric acid and cognitive function \u201cGout kills more wise men than simple\u201d. Eur Rev Med Pharmacol Sci 19:640\u2013646","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"729_CR5","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/eci.12677","volume":"46","author":"N Veronese","year":"2016","unstructured":"Veronese N, Carraro S, Bano G, Trevisan C, Solmi M, Luchini C, Manzato E, Caccialanza R, Sergi G, Nicetto D, Cereda E (2016) Hyperuricemia protects against low bone mineral density, osteoporosis and fractures: a systematic review and meta-analysis. Eur J Clin Invest 46:920\u2013930","journal-title":"Eur J Clin Invest"},{"key":"729_CR6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1536\/ihj.16-192","volume":"57","author":"N Maharani","year":"2016","unstructured":"Maharani N, Kuwabara M, Hisatome I (2016) Hyperuricemia and atrial fibrillation. Int Heart J 57:395\u2013399","journal-title":"Int Heart J"},{"key":"729_CR7","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.hrthm.2014.04.003","volume":"11","author":"L Tamariz","year":"2014","unstructured":"Tamariz L, Hernandez F, Bush A, Palacio A, Hare JM (2014) Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm 11:1102\u20131108","journal-title":"Heart Rhythm"},{"key":"729_CR8","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2169\/internalmedicine.50.4587","volume":"50","author":"T Liu","year":"2011","unstructured":"Liu T, Zhang X, Korantzopoulos P, Wang S, Li G (2011) Uric acid levels and atrial fibrillation in hypertensive patients. Intern Med 50:799\u2013803","journal-title":"Intern Med"},{"key":"729_CR9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1253\/circj.CJ-11-1111","volume":"76","author":"S Suzuki","year":"2012","unstructured":"Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Uejima T, Oikawa Y, Koike A, Nagashima K, Kirigaya H, Yajima J, Sawada H, Aizawa T, Yamashita T (2012) Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence. Circ J 76:607\u2013611","journal-title":"Circ J"},{"key":"729_CR10","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1016\/j.ijcard.2013.06.067","volume":"168","author":"TF Chao","year":"2013","unstructured":"Chao TF, Hung CL, Chen SJ, Wang KL, Chen TJ, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chen SA (2013) The association between hyperuricemia, left atrial size and new-onset atrial fibrillation. Int J Cardiol 168:4027\u20134032","journal-title":"Int J Cardiol"},{"key":"729_CR11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ijcard.2015.02.038","volume":"184","author":"X Xu","year":"2015","unstructured":"Xu X, Du N, Wang R, Wang Y, Cai S (2015) Hyperuricemia is independently associated with increased risk of atrial fibrillation: a meta-analysis of cohort studies. Int J Cardiol 184:699\u2013702","journal-title":"Int J Cardiol"},{"key":"729_CR12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2016.11.268","volume":"231","author":"M Kuwabara","year":"2017","unstructured":"Kuwabara M, Niwa K, Nishihara S, Nishi Y, Takahashi O, Kario K, Yamamoto K, Yamashita T, Hisatome I (2017) Hyperuricemia is an independent competing risk factor for atrial fibrillation. Int J Cardiol 231:137\u2013142","journal-title":"Int J Cardiol"},{"key":"729_CR13","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.numecd.2014.03.012","volume":"24","author":"SY Chuang","year":"2014","unstructured":"Chuang SY, Wu CC, Hsu PF, Chia-Yu Chen R, Liu WL, Hsu YY, Pan WH (2014) Hyperuricemia and incident atrial fibrillation in a normotensive elderly population in Taiwan. Nutr Metab Cardiovasc Dis 24:1020\u20131026","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"729_CR14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40618-015-0354-z","volume":"39","author":"A Mantovani","year":"2016","unstructured":"Mantovani A, Rigolon R, Pichiri I, Pernigo M, Bergamini C, Zoppini G, Bonora E, Targher G (2016) Hyperuricemia is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. J Endocrinol Invest 39:159\u2013167","journal-title":"J Endocrinol Invest"},{"key":"729_CR15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.amjcard.2013.04.012","volume":"112","author":"F Valbusa","year":"2013","unstructured":"Valbusa F, Bertolini L, Bonapace S, Zenari L, Zoppini G, Arcaro G, Byrne CD, Targher G (2013) Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus. Am J Cardiol 112:499\u2013504","journal-title":"Am J Cardiol"},{"key":"729_CR16","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.amjcard.2011.06.043","volume":"108","author":"L Tamariz","year":"2011","unstructured":"Tamariz L, Agarwal S, Soliman EZ, Chamberlain AM, Prineas R, Folsom AR, Ambrose M, Alonso A (2011) Association of serum uric acid with incident atrial fibrillation (from the atherosclerosis risk in communities [ARIC] study). Am J Cardiol 108:1272\u20131276","journal-title":"Am J Cardiol"},{"key":"729_CR17","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","volume":"11","author":"F Rahman","year":"2014","unstructured":"Rahman F, Kwan GF, Benjamin EJ (2014) Global epidemiology of atrial fibrillation. Nat Rev Cardiol 11:639\u2013654","journal-title":"Nat Rev Cardiol"},{"key":"729_CR18","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0140-6736(16)30968-0","volume":"388","author":"JS Healey","year":"2016","unstructured":"Healey JS, Oldgren J, Ezekowitz M, Zhu J, Pais P, Wang J, Commerford P, Jansky P, Avezum A, Sigamani A, Demasceno A, Reilly P, Grinvalds A, Nakamya J, Aje A, Almahmeed W, Moriarty A, Wallentin L, Yusuf S (2016) Connolly SJ; RE-LY Atrial Fibrillation Registry and Cohort Study Investigators. Occurrence of death and stroke in patients in 47 countries 1\u00a0year after presenting with atrial fibrillation: a cohort study. Lancet 388:1161\u20131169","journal-title":"Lancet"},{"key":"729_CR19","doi-asserted-by":"crossref","first-page":"16016","DOI":"10.1038\/nrdp.2016.16","volume":"2","author":"GY Lip","year":"2016","unstructured":"Lip GY, Fauchier L, Freedman SB, Van Gelder I, Natale A, Gianni C, Nattel S, Potpara T, Rienstra M, Tse HF, Lane DA (2016) Atrial fibrillation. Nat Rev Dis Primers 2:16016","journal-title":"Nat Rev Dis Primers"},{"key":"729_CR20","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.ijcard.2012.06.118","volume":"167","author":"A Banerjee","year":"2013","unstructured":"Banerjee A, Taillandier S, Olesen JB, Lane DA, Lallemand B, Lip GY, Fauchier L (2013) Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project. Int J Cardiol 167:2682\u20132687","journal-title":"Int J Cardiol"},{"key":"729_CR21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) Modification of diet in renal disease study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130:461\u2013470","journal-title":"Ann Intern Med"},{"key":"729_CR22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/01.CIR.0000080897.52664.94","volume":"108","author":"N Sattar","year":"2003","unstructured":"Sattar N, Gaw A, Scherbakova O, Ford I, O\u2019Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108:414\u2013419","journal-title":"Circulation"},{"key":"729_CR23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjcard.2003.09.028","volume":"93","author":"CJ Girman","year":"2004","unstructured":"Girman CJ, Rhodes T, Mercuri M, 4S Group and the AFCAPS\/TexCAPS Research Group et al (2004) The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force\/Texas Coronary Atherosclerosis Prevention Study (AFCAPS\/TexCAPS). Am J Cardiol 93:136\u2013141","journal-title":"Am J Cardiol"},{"key":"729_CR24","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","volume":"18","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 18:1609\u20131678","journal-title":"Europace"},{"key":"729_CR25","first-page":"1601","volume":"17","author":"SG Priori","year":"2015","unstructured":"Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekv\u00e5l TM, Spaulding C, Van Veldhuisen DJ, Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace 17:1601\u20131687","journal-title":"Europace"},{"key":"729_CR26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrcardio.2015.191","volume":"13","author":"LH Ling","year":"2016","unstructured":"Ling LH, Kistler PM, Kalman JM, Schilling RJ, Hunter RJ (2016) Comorbidity of atrial fibrillation and heart failure. Nat Rev Cardiol 13:131\u2013147","journal-title":"Nat Rev Cardiol"},{"key":"729_CR27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.194","volume":"13","author":"L Fabritz","year":"2016","unstructured":"Fabritz L, Guasch E, Antoniades C, Bardinet I, Benninger G, Betts TR, Brand E, Breithardt G, Bucklar-Suchankova G, Camm AJ, Cartlidge D, Casadei B, Chua WW, Crijns HJ, Deeks J, Hatem S, Hidden-Lucet F, K\u00e4\u00e4b S, Maniadakis N, Martin S, Mont L, Reinecke H, Sinner MF, Schotten U, Southwood T, Stoll M, Vardas P, Wakili R, West A, Ziegler A, Kirchhof P (2016) Expert consensus document: defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment. Nat Rev Cardiol 13:230\u2013237","journal-title":"Nat Rev Cardiol"},{"key":"729_CR28","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","volume":"67","author":"U Khosla","year":"2005","unstructured":"Khosla U, Zharikov S, Finch J, Nakagawa T, Roncal C, Mu W, Kratova K, Block E, Prabhakar S, Johnson R (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67:1739\u20131742","journal-title":"Kidney Int"},{"key":"729_CR29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1113\/jphysiol.2003.055913","volume":"555","author":"CE Berry","year":"2004","unstructured":"Berry CE, Hare JM (2004) Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555:589\u2013606","journal-title":"J Physiol"},{"key":"729_CR30","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.amjcard.2005.07.068","volume":"96","author":"M Kato","year":"2005","unstructured":"Kato M, Hisatome I, Tomikura Y, Kotani K, Kinugawa T, Ogino K, Ishida K, Igawa O, Shigemasa C, Somers V (2005) Status of endothelial dependent vasodilatation in patients with hyperuricemia. Am J Cardiol 96:1576\u20131578","journal-title":"Am J Cardiol"},{"key":"729_CR31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1185\/03007995.2015.1087980","volume":"2","author":"F Perez-Ruiz","year":"2015","unstructured":"Perez-Ruiz F, Becker MA (2015) Inflammation: a possible mechanism for a causative role of hyperuricemia\/gout in cardiovascular disease. Curr Med Res Opin 2:9\u201314","journal-title":"Curr Med Res Opin"},{"key":"729_CR32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijcard.2016.12.018","volume":"231","author":"N Li","year":"2017","unstructured":"Li N, Dobrev D (2017) Hyperuricemia: a causal player or a bystander linking inflammatory signaling and atrial fibrillation? Int J Cardiol 231:177\u2013178","journal-title":"Int J Cardiol"},{"key":"729_CR33","doi-asserted-by":"crossref","first-page":"21896","DOI":"10.1074\/jbc.M114.549642","volume":"289","author":"N El khoury","year":"2014","unstructured":"El khoury N, Mathieu S, Fiset C (2014) Interleukin-1\u03b2 reduces L-type Ca2+ current through protein kinase C\u03f5 activation in mouse heart. J Biol Chem 289:21896\u201321908","journal-title":"J Biol Chem"},{"key":"729_CR34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.12659\/MSM.890635","volume":"20","author":"O Sonmez","year":"2014","unstructured":"Sonmez O, Ertem FU, Vatankulu MA, Erdongan E, Tasal A, Kucukbuzcu S, Goktekin O (2014) Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation. Med Sci Monit 20:463\u2013470","journal-title":"Med Sci Monit"},{"key":"729_CR35","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2014.02.555","volume":"63","author":"S Nattel","year":"2014","unstructured":"Nattel S, Harada M (2014) Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol 63:2335\u20132345","journal-title":"J Am Coll Cardiol"},{"key":"729_CR36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","volume":"12","author":"YF Hu","year":"2015","unstructured":"Hu YF, Chen YJ, Lin YJ, Chen SA (2015) Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol 12:230\u2013243","journal-title":"Nat Rev Cardiol"},{"key":"729_CR37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2013.08.078","volume":"169","author":"N Wu","year":"2013","unstructured":"Wu N, Xu B, Xiang Y, Wu L, Zhang Y, Ma X, Tong S, Shu M, Song Z, Li Y, Zhong L (2013) Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis. Int J Cardiol 169:62\u201372","journal-title":"Int J Cardiol"},{"key":"729_CR38","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrcardio.2016.118","volume":"13","author":"S Nattel","year":"2016","unstructured":"Nattel S, Dobrev D (2016) Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation. Nat Rev Cardiol 13:575\u2013590","journal-title":"Nat Rev Cardiol"},{"key":"729_CR39","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/STROKEAHA.107.492595","volume":"39","author":"AG Douen","year":"2008","unstructured":"Douen AG, Pageau N, Medic S (2008) Serial electrocardiographic assessments significantly improve detection of atrial fibrillation 2.6-fold in patients with acute stroke. Stroke 39:480\u2013482","journal-title":"Stroke"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-017-0729-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0729-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0729-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T05:01:44Z","timestamp":1516856504000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-017-0729-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,15]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["729"],"URL":"https:\/\/doi.org\/10.1007\/s40618-017-0729-4","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,15]]}}}